Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30672208 | 1.00 | PTGES (0.60) | PTGESPTGS2 | |
| SCHEMBL18344164 | 0.85 | — | — | |
| SCHEMBL29551098 | 0.83 | PTGES (0.61) | PTGESPTGS2 | |
| SCHEMBL24462181 | 0.83 | PTGES (0.61) | PTGESPTGS2 | |
| SCHEMBL19698128 | 0.80 | PTGES (0.56) | PTGESPTGS2 | |
| SCHEMBL13735326 | 0.80 | PTGES (0.56) | PTGESPTGS2 | |
| SCHEMBL17830179 | 0.80 | PTGES (0.56) | PTGESPTGS2 | |
| SCHEMBL29435909 | 0.80 | PTGES (0.56) | PTGESPTGS2 | |
| SCHEMBL13838771 | 0.80 | PTGES (0.56) | PTGESPTGS2 | |
| SCHEMBL13735931 | 0.80 | PTGES (0.56) | PTGESPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391774-A1 | Novel Compounds | AC IMMUNE SA (CH) | 2023-12-07 | — | — | US | disclosed |
| WO-2022078971-A1 | NOVEL COMPOUNDS | AC IMMUNE SA (CH) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391774-A1 | Novel Compounds | MAPT, PSEN2, PSEN1 | PTGES 2396/4885PTGS2 2748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.